has been cited by the following article(s):
|
[1]
|
Modified APJ Receptor Peptide Ligands as Postconditioning Drugs in Myocardial Ischaemia/Reperfusion Injury
International Journal of Peptide Research and Therapeutics,
2023
DOI:10.1007/s10989-023-10498-2
|
|
|
|
|
[2]
|
Prognostic Value of Combining Apelin-12 and Estimated Glomerular Filtration Rate in Patients with ST-Segment Elevation Myocardial Infarction
Journal of Interventional Cardiology,
2022
DOI:10.1155/2022/2272928
|
|
|
|
|
[3]
|
Structural apelin analogues: mitochondrial ROS inhibition and cardiometabolic protection in myocardial ischaemia reperfusion injury
British Journal of Pharmacology,
2015
DOI:10.1111/bph.13038
|
|
|
|
|
[4]
|
Structural apelin analogues: mitochondrial ROS inhibition and cardiometabolic protection in myocardial ischaemia reperfusion injury
British Journal of Pharmacology,
2015
DOI:10.1111/bph.13038
|
|
|
|
|
[5]
|
Apelin-12 and its structural analog enhance antioxidant defense in experimental myocardial ischemia and reperfusion
Molecular and Cellular Biochemistry,
2014
DOI:10.1007/s11010-014-2008-4
|
|
|
|
|
[6]
|
Nitric oxide synthase mediates the apelin-induced improvement of myocardial postischemic metabolic and functional recovery
Open Journal of Molecular and Integrative Physiology,
2012
DOI:10.4236/ojmip.2012.21001
|
|
|
|